Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 266

1.

Fixed-dose isosorbide dinitrate-hydralazine: race-based cardiovascular medicine benefit or mirage?

Ferdinand KC.

J Law Med Ethics. 2008 Fall;36(3):458-63. doi: 10.1111/j.1748-720X.2008.291.x. Review.

PMID:
18840236
[PubMed - indexed for MEDLINE]
2.

Editorial commentary on fixed combination isosorbide dinitrate/hydralazine for nitric-oxide-enhancing therapy in heart failure.

Flack JM.

Expert Opin Pharmacother. 2007 Feb;8(3):275-7.

PMID:
17266462
[PubMed - indexed for MEDLINE]
3.

Early and sustained benefit on event-free survival and heart failure hospitalization from fixed-dose combination of isosorbide dinitrate/hydralazine: consistency across subgroups in the African-American Heart Failure Trial.

Taylor AL, Ziesche S, Yancy CW, Carson P, Ferdinand K, Taylor M, Adams K, Olukotun AY, Ofili E, Tam SW, Sabolinski ML, Worcel M, Cohn JN; African-American Heart Failure Trial Investigators.

Circulation. 2007 Apr 3;115(13):1747-53. Epub 2007 Mar 19.

PMID:
17372175
[PubMed - indexed for MEDLINE]
Free Article
4.

Combination of isosorbide dinitrate and hydralazine in blacks with heart failure.

Taylor AL, Ziesche S, Yancy C, Carson P, D'Agostino R Jr, Ferdinand K, Taylor M, Adams K, Sabolinski M, Worcel M, Cohn JN; African-American Heart Failure Trial Investigators.

N Engl J Med. 2004 Nov 11;351(20):2049-57. Epub 2004 Nov 8. Erratum in: N Engl J Med. 2005 Mar 24;352(12):1276.

PMID:
15533851
[PubMed - indexed for MEDLINE]
Free Article
5.

Effectiveness of hydralazine/isosorbide dinitrate in racial/ethnic subgroups with heart failure.

Hammermeister KE, Fairclough D, Emsermann CB, Hamman R, Ho M, Phibbs S, Plomondon M, Valuck R, West D, Steiner JF.

Clin Ther. 2009 Mar;31(3):632-43. doi: 10.1016/j.clinthera.2009.03.019.

PMID:
19393854
[PubMed - indexed for MEDLINE]
6.

BiDil (isosorbide dinitrate and hydralazine): a new fixed-dose combination of two older medications for the treatment of heart failure in black patients.

Carmody MS, Anderson JR.

Cardiol Rev. 2007 Jan-Feb;15(1):46-53. Review.

PMID:
17172884
[PubMed - indexed for MEDLINE]
7.

Isosorbide dinitrate and hydralazine as therapy for African Americans with heart failure; a failed paradigm?

Yancy CW, Feldman A.

Clin Transl Sci. 2009 Aug;2(4):309-11. doi: 10.1111/j.1752-8062.2009.00130.x. No abstract available.

PMID:
20443909
[PubMed - indexed for MEDLINE]
8.

Effects of ACE inhibitors or beta-blockers in patients treated with the fixed-dose combination of isosorbide dinitrate/hydralazine in the African-American Heart Failure Trial.

Ghali JK, Tam SW, Ferdinand KC, Lindenfeld J, Sabolinski ML, Taylor AL, Worcel M, Curry CL, Cohn JN; A-HeFT Investigators.

Am J Cardiovasc Drugs. 2007;7(5):373-80.

PMID:
18041162
[PubMed - indexed for MEDLINE]
9.

Evidence for the continued safety and tolerability of fixed-dose isosorbide dinitrate/hydralazine in patients with chronic heart failure (the extension to African-American Heart Failure Trial).

Yancy CW, Ghali JK, Braman VM, Sabolinski ML, Worcel M, Archambault WT, Franciosa JA.

Am J Cardiol. 2007 Aug 15;100(4):684-9. Epub 2007 Jun 26.

PMID:
17697829
[PubMed - indexed for MEDLINE]
10.

Isosorbide dinitrate-hydralazine improves outcomes in African Americans with heart failure.

Colvin-Adams M, Taylor AL.

Cleve Clin J Med. 2007 Mar;74(3):227-34. Review.

PMID:
17375804
[PubMed - indexed for MEDLINE]
Free Article
11.

Fixed combination isosorbide dinitrate-hydralazine for nitric-oxide-enhancing therapy in heart failure.

Franciosa JA.

Expert Opin Pharmacother. 2006 Dec;7(18):2521-31. Review.

PMID:
17150006
[PubMed - indexed for MEDLINE]
12.

BiDil for heart failure in black patients: The U.S. Food and Drug Administration perspective.

Temple R, Stockbridge NL.

Ann Intern Med. 2007 Jan 2;146(1):57-62.

PMID:
17200223
[PubMed - indexed for MEDLINE]
13.

Effects of nitrates and hydralazine in heart failure: clinical evidence before the african american heart failure trial.

Elkayam U, Bitar F.

Am J Cardiol. 2005 Oct 10;96(7B):37i-43i. Epub 2005 Aug 9. Review.

PMID:
16226934
[PubMed - indexed for MEDLINE]
14.

The African American Heart Failure Trial: a clinical trial update.

Taylor AL.

Am J Cardiol. 2005 Oct 10;96(7B):44-8. Epub 2005 Aug 9. Review.

PMID:
16226935
[PubMed - indexed for MEDLINE]
15.

Isosorbide dinitrate-hydralazine combination therapy in African Americans with heart failure.

Echols MR, Yancy CW.

Vasc Health Risk Manag. 2006;2(4):423-31. Review.

PMID:
17323596
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Isosorbide dinitrate and hydralazine hydrochloride: a review of efficacy and safety.

Ferdinand KC.

Expert Rev Cardiovasc Ther. 2005 Nov;3(6):993-1001. Review.

PMID:
16292990
[PubMed - indexed for MEDLINE]
17.

Drug success signals a new trend. A "race-based" medication is a step toward individualized care.

[No authors listed]

Heart Advis. 2005 Apr;8(4):4-5. No abstract available.

PMID:
16138392
[PubMed - indexed for MEDLINE]
18.

The isosorbide-hydralazine story: is there a case for race-based cardiovascular medicine?

Ferdinand KC.

J Clin Hypertens (Greenwich). 2006 Mar;8(3):156-8. No abstract available.

PMID:
16522991
[PubMed - indexed for MEDLINE]
19.

The use of race and ethnicity in medicine: lessons from the African-American Heart Failure Trial.

Cohn JN.

J Law Med Ethics. 2006 Fall;34(3):552-4, 480.

PMID:
17144178
[PubMed - indexed for MEDLINE]
20.

BiDil for heart failure.

[No authors listed]

Med Lett Drugs Ther. 2005 Sep 26;47(1218):77-8.

PMID:
16186789
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk